Hidden gut issue in Crohn's patients under biologics under spotlight
NCT ID NCT03915262
First seen Jan 04, 2026 · Last updated May 20, 2026 · Updated 21 times
Summary
This study looks at how often people with active Crohn's disease have a problem called exocrine pancreatic insufficiency (EPI), where the pancreas doesn't make enough enzymes to digest food properly. Researchers will check 50 adults before and 14 weeks after they start a biologic therapy for Crohn's. The goal is to understand how common EPI is and how it changes with treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CROHN DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Service d'Hépato-Gastroentérologie, Centre Hospitalier Lyon-Sud, HCL
RECRUITINGPierre-Bénite, 69495, France
Contact
Contact
Contact
Contact
Contact
Contact
Conditions
Explore the condition pages connected to this study.